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Abstract
OBJECTIVE—To evaluate the impact of combined exposure to intra-amniotic inflammation and 
neonatal respiratory distress syndrome (RDS) on the development of intraventricular hemorrhage 
(IVH) in preterm neonates.
METHODS—This retrospective cohort study includes 207 consecutive preterm births (24.0–33.0 
weeks of gestation). Intra-amniotic inflammation was defined as an amniotic fluid matrix 
metalloproteinase-8 concentration >23 ng/mL. According to McMenamin’s classification, IVH 
was defined as grade II or higher when detected by neurosonography within the first weeks of life.
RESULTS—1) IVH was diagnosed in 6.8% (14/207) of neonates in the study population; 2) IVH 
was frequent among newborns exposed to intra-amniotic inflammation when followed by 
postnatal RDS (33% [6/18]). The frequency of IVH was 7% (8/115) among neonates exposed 
either to these conditions—intra-amniotic inflammation or RDS—and 0% (0/64) among those 
who were not exposed to these conditions; and 3) neonates exposed to intra-amniotic 
inflammation and postnatal RDS had a significantly higher risk of IVH than those with only intra-
Correspondence to: Joon-Seok Hong, MD, PhD, Department of Obstetrics and Gynecology, Seoul National University Bundang 
Hospital, Seongnam-si, Gyeonggi-do, 13620, Korea; Tel: +82-31-787-7256, Fax: +82-31-787-4054; hjsobgy@snubh.org. 
Disclosure Statement: The authors report no conflict of interest.
Dr. Romero has contributed to this work as part of his official duties as an employee of the United States Federal Government.
HHS Public Access
Author manuscript
J Perinat Med. Author manuscript; available in PMC 2018 March 13.
Published in final edited form as:
J Perinat Med. 2018 January 26; 46(1): 9–20. doi:10.1515/jpm-2016-0348.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
amniotic inflammation [odds ratio (OR), 4.6; 95% confidence interval (CI), 1.1–19.3) and those 
with RDS alone (OR, 5.6; 95% CI, 1.0–30.9), after adjusting for gestational age.
CONCLUSION—The combined exposure to intra-amniotic inflammation and postnatal RDS 
markedly increased the risk of IVH in preterm neonates.
Keywords
brain injury; hypoxic-ischemic injury; intra-amniotic inflammation; periventricular-
intraventricular hemorrhage; preterm birth
Introduction
Intraventricular hemorrhage (IVH) remains one of the leading causes of morbidity and 
mortality in the preterm neonate [1–13]. A substantial body of evidence indicates that IVH is 
a predictor of periventricular leukomalacia [14–17], neurodevelopmental delay [3, 12, 13, 
18] and cerebral palsy [19–23]. Even low-grade IVH is associated with poor 
neurodevelopmental outcomes [12, 24]. Risk factors that have been linked to the 
development of IVH include early gestational age at birth [4, 25–28], intrauterine/fetal 
inflammation [1, 4, 5, 29–33], spontaneous preterm birth [4, 34], early onset of neonatal 
sepsis [35], respiratory distress syndrome (RDS) [25, 36–39], hypoxia-ischemia [40, 41], 
and non-use of antenatal corticosteroids [26, 35].
Substantial evidence indicates that intra-amniotic infection/inflammation is causally linked 
to preterm delivery [5, 42–62]. The inflammatory response has been implicated in the 
genesis of fetal brain injury in humans [1, 5, 15, 29, 30] as well as in experimental animal 
models [63–67]. However, some recent studies [4, 68–70] reported that acute histologic 
chorioamnionitis was not an independent risk factor for the development of IVH. Moreover, 
reports suggest that antenatal exposure to an inflammatory response accelerates fetal lung 
maturation [71, 72] and decreases the risk of developing of RDS [73–75]. In a nationwide 
population-based study, spontaneous preterm infants were at increased risk of cerebral palsy 
but at decreased risk of RDS [76]. These findings raise the question of how the 
inflammatory response increases the risk of IVH despite decreasing the risk of RDS, which 
is known as a risk factor for IVH.
The purpose of this study was to evaluate the relationship among the antenatal inflammatory 
response, the postnatal occurrence of RDS, and the development of IVH in preterm 
neonates.
Materials and methods
Study design
This retrospective cohort study includes 207 consecutive singleton preterm neonates who 
were born in the Seoul National University Hospital from 1995 to 2007 and met the 
following criteria: 1) gestational age at birth between 24.0 and 33.0 weeks; 2) absence of 
chromosomal abnormalities and major structural anomalies; 3) collection of amniotic fluid 
(AF) within 120 hours of delivery, either by abdominal amniocentesis or at the time of 
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cesarean delivery; and 4) neurosonographic examination within seven days of birth. We 
reviewed the medical records to determine the clinical and demographic characteristics of 
the mothers and their neonates. The demographic characteristics included age, parity, and 
gestational age at birth. The clinical characteristics consisted of antenatal corticosteroid 
administration, histopathological evaluation of the placenta, cause of preterm birth 
(spontaneous vs. medically indicated preterm birth) and delivery mode (cesarean vs. vaginal 
delivery). We also included gender, umbilical arterial blood gas analysis, and Apgar scoring 
at 1 minute and 5 minutes.
Diagnosis of neonatal respiratory distress syndrome and intraventricular hemorrhage
Neonatal RDS was defined as the presence of respiratory distress, increased oxygen 
requirement (FiO2 > 0.4), and diagnostic radiological findings in the absence of evidence of 
any other causes of respiratory distress as described previously [74].
Neurosonographic examinations were performed as part of routine clinical care in preterm 
neonates. Sonographic findings of periventricular-intraventricular hemorrhage (PV-IVH) 
were graded into three categories according to McMenamin’s classification [2]: 1) grade I: 
subependymal hemorrhage with minimal or no IVH; 2) grade II: IVH, but neither lateral 
ventricle completely filled with blood, with or without mild ventricular dilatation; and 3) 
grade III: IVH completely filling and distending at least one lateral ventricle. IVH was 
defined as Grade II or higher by McMenamin’s classification of PV-IVH. For a meaningful 
temporal relationship among intra-amniotic inflammation, neonatal RDS, and the 
development of IVH, the results of neurosonographic examinations performed within seven 
days of birth were included.
Definition of intra-amniotic inflammation
Amniotic fluid not used for clinical studies was stored at −70°C for future research purposes. 
The stored AF was analyzed for matrix metalloproteinase-8 (MMP-8), which was measured 
with a commercially available enzyme-linked immunosorbent assay (Amersham Pharmacia 
Biotech, Inc., Amersham, UK), as previously reported [77]. The measurement was not 
performed in 10 patients because of the lack of available AF. The sensitivity of the test was 
0.3 ng/mL. Intra- and inter-assay coefficients of variation for each were <10%. Intra-
amniotic inflammation was defined as an elevated AF MMP-8 concentration (>23 ng/mL), 
as previously reported [77]. The Institutional Review Board of the Seoul National University 
Hospital approved the collection and use of these samples for research purposes. This 
University Hospital has a Federal Wide Assurance with the Office for Human Research 
Protection of the Department of Health and Human Services of the United States.
Diagnosis of acute histologic chorioamnionitis and acute funisitis
Acute histologic chorioamnionitis was defined in the presence of acute inflammatory 
changes upon examination of the choriodecidua and amnion, respectively; acute funisitis 
was diagnosed in the presence of neutrophil infiltration into the umbilical vessel walls or 
Wharton’s jelly with the use of criteria previously reported [5, 59].
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Statistical analysis
The Mann-Whitney U-test was used for comparison of continuous variables. For the 
dichotomized variables, a Fisher’s exact test was performed. Multiple logistic regression 
analysis was used to examine the relationship of intra-amniotic inflammation and RDS to 
the probability of the occurrence of IVH after adjusting for variables that had a significant 
correlation or a tendency (P < 0.1) including gestational age at birth, male gender, and acute 
histologic chorioamnionitis. A probability value < 0.05 was considered as significant. SPSS 
21.0 for Windows (IBM, Armonk, NY, USA) was used for statistical analyses.
Results
Characteristics of the study population
Table 1 describes the characteristics and results of the neurosonographic examinations 
performed in the study population. A total of 258 neurosonographic examinations were 
performed on 207 neonates (mean 1.3 ±0.5 neurosonographic examinations/neonate) within 
seven days of birth; 43 (31%) newborns received multiple scans. IVH was diagnosed in 
6.8% (14/207) of neonates in the study population.
Table 2 compares the clinical characteristics according to the development of IVH. 
Gestational age was significantly lower in neonates with IVH than those without IVH (P < 
0.005). Neonates with IVH had higher rates of RDS and the presence of histologic 
chorioamnionitis than those without IVH (P < 0.05 for each). Spontaneous preterm birth and 
male gender were more frequent in neonates with IVH than in those without IVH, but the 
differences did not reach statistical significance. The rates of antenatal corticosteroid use and 
cesarean delivery were not significantly different between groups. Among the 197 neonates 
whose AF was measured for MMP-8 concentrations, neonates with IVH had a significantly 
higher median AF MMP-8 concentration (P < 0.05) and a higher rate of intra-amniotic 
inflammation (P < 0.01) than those without IVH.
The relationship among intra-amniotic inflammation, respiratory distress syndrome and 
intraventricular hemorrhage
Table 3 shows the multivariate analysis for the factors that had a probability of < 0.1 in the 
univariate analysis. Because the presence of intra-amniotic inflammation was closely linked 
to the occurrence of histologic chorioamnionitis, they were included separately in the 
multivariate analysis model. When acute histologic chorioamnionitis was included in the 
multivariate analysis, gestational age at birth was an independent risk factor for the 
development of IVH [odds ratio (OR), 0.70; 95% confidence interval (CI), 0.52–0.94). 
When the presence of intra-amniotic inflammation was included in the analysis, this factor 
(OR, 7.88; 95% CI, 1.63–38.1) and the occurrence of RDS (OR, 6.50; 95% CI, 1.69–25.1) 
were independent risk factors for the development of IVH. When these two variables (intra-
amniotic inflammation and acute histologic chorioamnionitis) were included together in the 
multivariate analysis, the presence of intra-amniotic inflammation (OR, 25.3; 95% CI, 1.89–
338.6) and the occurrence of RDS (OR, 4.63; 95% CI, 1.10–19.4) were independently 
associated with the development of IVH.
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The effect of combined exposure to intra-amniotic inflammation and postnatal respiratory 
distress syndrome on intraventricular hemorrhage
Table 4 presents the clinical characteristics and outcomes of the study population according 
to the presence or absence of intra-amniotic inflammation and the occurrence of neonatal 
RDS. IVH was frequent among newborns exposed to intra-amniotic inflammation when 
followed by postnatal RDS (33% [6/18]). The frequency of IVH was 7% (8/115) among 
neonates exposed to either of these conditions (intra-amniotic inflammation or RDS) and 0% 
(0/64) among those who were not exposed to these conditions. Figure 1 displays the 
comparison of rates of IVH among groups according to the presence or absence of intra-
amniotic inflammation and the occurrence of RDS. Neonates who were exposed to both of 
these conditions had a significantly higher risk of IVH than those with RDS alone (OR, 
5.63; 95% CI, 1.03–30.87) and those with intra-amniotic inflammation alone (OR, 4.56; 
95% CI, 1.08–19.26) after adjusting for the gestational age at birth.
Discussion
Principal findings of this study
IVH occurred in 6.8% (14/207) of the preterm singleton neonates (gestational age between 
24.0–33.0 weeks). Intra-amniotic inflammation and neonatal RDS were independent risk 
factors for the development of IVH. Moreover, the impact of the combined exposure to intra-
amniotic inflammation and postnatal RDS was considerably greater than that of separate 
exposures to either of the conditions.
Intra-amniotic inflammation and intraventricular hemorrhage
Strong evidence suggests that prenatal exposure to an inflammatory response is associated 
with the development of IVH [1, 5, 29–34, 78, 79]. The germinal matrix zone of preterm 
neonates is supported by a single cell layer of endothelium without muscle coats and is 
prone to hemorrhage [80]. The inflammatory response exerts a direct neurotoxic effect [81–
83], leads to circulatory disturbances [80], and induces adhesion of leukocytes to fragile 
vessels [84], all of which may increase the risk of IVH. The findings of our study support 
the view that prenatal exposure to an inflammatory response plays an important role in the 
development of IVH in preterm neonates.
Prenatal exposure to an inflammatory response can be determined by elevated 
concentrations of AF inflammatory mediators [49, 54, 77, 85–104], AF white blood cell 
count [105–107], the presence of inflammatory changes in the fetal membranes or acute 
histologic chorioamnionitis [59, 78, 106, 108–111], and the concentration of cytokines in 
umbilical cord blood [1, 48, 112–116]. In the study herein, intra-amniotic inflammation was 
defined as an elevated AF MMP-8 concentration (>23 ng/mL); previous studies have shown 
that the concentration of AF MMP-8 is an excellent marker of intra-amniotic infection 
and/or inflammation, the fetal inflammatory response syndrome, impeding preterm delivery, 
and neonatal morbidity [54, 57, 58, 77, 86, 100, 117]. The measurement of AF cytokine 
concentrations has some advantages over other tools: 1) histologic examination cannot be 
performed antenatally and the results may not be available in time for clinical management 
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decisions; 2) histologic chorioamnionitis is frequently found in patients with active labor 
[118]; and 3) amniocentesis is frequently used for the assessment of lung maturity.
Recent reports have claimed that acute histologic chorioamnionitis is not an independent risk 
factor for the development of IVH [4, 68–70], which is consistent with our findings (Table 
3). However, upon further analysis, we found that intra-amniotic inflammation was an 
independent risk factor, even after adjusting for other confounding variables. Acute 
histologic chorioamnionitis represents a maternal inflammatory response in the fetal 
membranes in response to chemotactic stimuli within the amniotic cavity [108]. Therefore, 
intra-amniotic inflammation is a better index of the risk of fetal systemic inflammation than 
histologic chorioamnionitis. Indeed, most neutrophils in the amniotic cavity are of fetal 
origin [59, 119].
The relationship between neonatal respiratory distress syndrome and intraventricular 
hemorrhage
Several studies support that RDS is a risk factor for the development of IVH [25, 36, 37, 
120, 121]. RDS is associated with the fluctuation of cerebral blood flow [122–124], low 
blood pressure [125], use of mechanical ventilation and hypoxia-ischemia [126], all of 
which increase the risk of IVH. In the current study, neonates with RDS had an OR of 3.71 
(95% CI, 1.20–11.5; P<0.05) for the development of IVH. Moreover, neonates with 
combined exposure to intra-amniotic inflammation and subsequent RDS had a significantly 
higher risk of developing IVH than those with intra-amniotic inflammation alone, even after 
adjusting for gestational age at birth.
Does intra-amniotic inflammation sensitize the immature brain to postnatal injury?
An important question is whether combined exposure to intra-amniotic inflammation and 
postnatal RDS has a synergistic effect on the development of IVH and brain damage in 
preterm neonates. Our findings showed that combined exposure of intra-amniotic 
inflammation and postnatal RDS markedly increases the risk for the development of IVH. 
Such findings are in keeping with the results of other studies in humans [127] as well as in 
animals [128–135]. In animal models, the impact of combined exposure to inflammation and 
postnatal hypoxic-ischemic injury was greater than when either of the conditions was 
induced separately [128–135]. Indeed, Nelson and Grether [127] found that the risk of 
unexplained spastic cerebral palsy in neonates with exposure to both infection/birth-
asphyxiating conditions was considerably greater than the risk in those with either condition 
alone, and was 78 times greater than the risk in those without exposure to either of these 
conditions.
Other factors related to the development of intraventricular hemorrhage
In the study herein, corticosteroid use and cesarean delivery did not show protective effects 
against the development of IVH. Roberts and Dalziel [136] demonstrated that antenatal 
corticosteroid treatment decreases the occurrence of cerebroventricular hemorrhage in their 
meta-analysis, which included 2,872 infants from 13 studies. However, we could not detect 
this effect in the present study. Possible explanations for this finding include: 1) the small 
sample size in our study population; 2) selection bias of corticosteroid use (in the study 
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period, all patients were eligible for receiving antenatal steroids); 3) there was no adjustment 
for an incomplete course of steroids.
Whether cesarean delivery can prevent IVH is controversial. Although some have reported 
that cesarean delivery prevents the development of IVH [137–140], other investigators [4, 
26, 78, 141] have found that the risk of IVH was not influenced by mode of delivery. In our 
study, the mode of delivery was not associated with the development of IVH.
Clinical implications
The major clinical implication of our study is that the presence or absence of intra-amniotic 
inflammation contributes to the estimate of risk for the subsequent development of IVH. 
Moreover, if RDS occurs in the neonates who were exposed to intra-amniotic inflammation, 
the risk of IVH is greatly increased. It seems paradoxical that intra-amniotic inflammation 
decreases the risk of neonatal RDS but increases the risk of IVH. In the current study, 
neonates with intra-amniotic inflammation had a significantly lower rate of the occurrence 
of RDS than those without intra-amniotic inflammation [21% (18/84) in the intra-amniotic 
inflammation group vs. 43% (49/113) in the non-intra-amniotic inflammation group; 
P<0.001 after adjusting for gestational age at birth]. However, although 9% (18/197) of 
preterm neonates were affected by combined intra-amniotic inflammation and postnatal 
RDS, 43% (6/14) of cases with IVH were from those neonates. These findings suggest that 
preterm neonates exposed to intra-amniotic inflammation and subsequent postnatal RDS are 
at great risk of the development of IVH and require evaluation and more intense 
surveillance.
In conclusion, antenatal intra-amniotic inflammation and postnatal RDS are independent risk 
factors for the development of IVH, and the combined exposure of these two factors 
markedly increases the risk of IVH in preterm neonates.
Acknowledgments
Funding: National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 
2011-0000195), and in part by Seoul National University Bundang Hospital Research Fund (No. 11-2011-018). The 
work of Dr. Romero was supported by the Perinatology Research Branch, Program for Perinatal Research and 
Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human 
Development, National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS) 
and, in part, with Federal funds from NICHD/NIH/DHHS under Contract No. HHSN275201300006C.
References
1. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response 
syndrome. Am J Obstet Gynecol. 1998; 179:194–202. [PubMed: 9704787] 
2. McMenamin JB, Shackelford GD, Volpe JJ. Outcome of neonatal intraventricular hemorrhage with 
periventricular echodense lesions. Ann Neurol. 1984; 15:285–90. [PubMed: 6721450] 
3. Ment LR, Vohr B, Allan W, Katz KH, Schneider KC, Westerveld M, et al. Change in cognitive 
function over time in very low-birth-weight infants. JAMA. 2003; 289:705–11. [PubMed: 
12585948] 
4. Vergani P, Locatelli A, Doria V, Assi F, Paterlini G, Pezzullo JC, et al. Intraventricular hemorrhage 
and periventricular leukomalacia in preterm infants. Obstet Gynecol. 2004; 104:225–31. [PubMed: 
15291991] 
OH et al. Page 7
J Perinat Med. Author manuscript; available in PMC 2018 March 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
5. Yoon BH, Romero R, Kim CJ, Jun JK, Gomez R, Choi JH, et al. Amniotic fluid interleukin-6: a 
sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and 
prediction of perinatal morbidity. Am J Obstet Gynecol. 1995; 172:960–70. [PubMed: 7892891] 
6. Vohr B, Ment LR. Intraventricular hemorrhage in the preterm infant. Early Hum Dev. 1996; 44:1–
16. [PubMed: 8821891] 
7. Perlman JM, Broyles RS, Rogers CG. Neonatal neurologic characteristics of preterm twin infants 
<1,250 gm birth weight. Pediatr Neurol. 1997; 17:322–6. [PubMed: 9436796] 
8. Baschat AA, Gembruch U, Viscardi RM, Gortner L, Harman CR. Antenatal prediction of 
intraventricular hemorrhage in fetal growth restriction: what is the role of Doppler? Ultrasound 
Obstet Gynecol. 2002; 19:334–9. [PubMed: 11952960] 
9. Valcamonico A, Accorsi P, Sanzeni C, Martelli P, La Boria P, Cavazza A, et al. Mid- and long-term 
outcome of extremely low birth weight (ELBW) infants: an analysis of prognostic factors. J Matern 
Fetal Neonatal Med. 2007; 20:465–71. [PubMed: 17674256] 
10. Kent AL, Wright IM, Abdel-Latif ME, New South W. Australian Capital Territory Neonatal 
Intensive Care Units Audit G. Mortality and adverse neurologic outcomes are greater in preterm 
male infants. Pediatrics. 2012; 129:124–31. [PubMed: 22184652] 
11. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal outcomes of 
extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010; 
126:443–56. [PubMed: 20732945] 
12. Mukerji A, Shah V, Shah PS. Periventricular/Intraventricular Hemorrhage and Neurodevelopmental 
Outcomes: A Meta-analysis. Pediatrics. 2015; 136:1132–43. [PubMed: 26598455] 
13. Payne AH, Hintz SR, Hibbs AM, Walsh MC, Vohr BR, Bann CM, et al. Neurodevelopmental 
outcomes of extremely low-gestational-age neonates with low-grade periventricular-
intraventricular hemorrhage. JAMA Pediatr. 2013; 167:451–9. [PubMed: 23460139] 
14. Larroque B, Marret S, Ancel PY, Arnaud C, Marpeau L, Supernant K, et al. White matter damage 
and intraventricular hemorrhage in very preterm infants: the EPIPAGE study. J Pediatr. 2003; 
143:477–83. [PubMed: 14571224] 
15. Yoon BH, Romero R, Yang SH, Jun JK, Kim IO, Choi JH, et al. Interleukin-6 concentrations in 
umbilical cord plasma are elevated in neonates with white matter lesions associated with 
periventricular leukomalacia. Am J Obstet Gynecol. 1996; 174:1433–40. [PubMed: 9065108] 
16. Armstrong DL, Sauls CD, Goddard-Finegold J. Neuropathologic findings in short-term survivors 
of intraventricular hemorrhage. Am J Dis Child. 1987; 141:617–21. [PubMed: 3578185] 
17. Volpe JJ. Intraventricular hemorrhage and brain injury in the premature infant. Neuropathology and 
pathogenesis. Clin Perinatol. 1989; 16:361–86. [PubMed: 2663307] 
18. Vohr BR, Wright LL, Dusick AM, Mele L, Verter J, Steichen JJ, et al. Neurodevelopmental and 
functional outcomes of extremely low birth weight infants in the National Institute of Child Health 
and Human Development Neonatal Research Network, 1993–1994. Pediatrics. 2000; 105:1216–
26. [PubMed: 10835060] 
19. Futagi Y, Toribe Y, Ogawa K, Suzuki Y. Neurodevelopmental outcome in children with 
intraventricular hemorrhage. Pediatr Neurol. 2006; 34:219–24. [PubMed: 16504792] 
20. Vohr B, Allan WC, Scott DT, Katz KH, Schneider KC, Makuch RW, et al. Early-onset 
intraventricular hemorrhage in preterm neonates: incidence of neurodevelopmental handicap. 
Semin Perinatol. 1999; 23:212–7. [PubMed: 10405190] 
21. Allan WC, Vohr B, Makuch RW, Katz KH, Ment LR. Antecedents of cerebral palsy in a 
multicenter trial of indomethacin for intraventricular hemorrhage. Arch Pediatr Adolesc Med. 
1997; 151:580–5. [PubMed: 9193243] 
22. Dunin-Wasowicz D, Rowecka-Trzebicka K, Milewska-Bobula B, Kassur-Siemienska B, Bauer A, 
Idzik M, et al. Risk factors for cerebral palsy in very low-birthweight infants in the 1980s and 
1990s. J Child Neurol. 2000; 15:417–20. [PubMed: 10868787] 
23. Msall ME, Buck GM, Rogers BT, Merke D, Catanzaro NL, Zorn WA. Risk factors for major 
neurodevelopmental impairments and need for special education resources in extremely premature 
infants. J Pediatr. 1991; 119:606–14. [PubMed: 1919894] 
OH et al. Page 8
J Perinat Med. Author manuscript; available in PMC 2018 March 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
24. Patra K, Wilson-Costello D, Taylor HG, Mercuri-Minich N, Hack M. Grades I–II intraventricular 
hemorrhage in extremely low birth weight infants: effects on neurodevelopment. J Pediatr. 2006; 
149:169–73. [PubMed: 16887428] 
25. Gleissner M, Jorch G, Avenarius S. Risk factors for intraventricular hemorrhage in a birth cohort of 
3721 premature infants. J Perinat Med. 2000; 28:104–10. [PubMed: 10875094] 
26. Riskin A, Riskin-Mashiah S, Bader D, Kugelman A, Lerner-Geva L, Boyko V, et al. Delivery mode 
and severe intraventricular hemorrhage in single, very low birth weight, vertex infants. Obstet 
Gynecol. 2008; 112:21–8. [PubMed: 18591303] 
27. Bhandari V, Buhimschi CS, Han CS, Lee SY, Pettker CM, Campbell KH, et al. Cord blood 
erythropoietin and interleukin-6 for prediction of intraventricular hemorrhage in the preterm 
neonate. J Matern Fetal Neonatal Med. 2011; 24:673–9. [PubMed: 20937006] 
28. Kwak HM, Shin MY, Cha HH, Choi SJ, Lee JH, Kim JS, et al. The efficacy of cefazolin plus 
macrolide (erythromycin or clarithromycin) versus cefazolin alone in neonatal morbidity and 
placental inflammation for women with preterm premature rupture of membranes. Placenta. 2013; 
34:346–52. [PubMed: 23465535] 
29. Viscardi RM, Hashmi N, Gross GW, Sun CC, Rodriguez A, Fairchild KD. Incidence of invasive 
ureaplasma in VLBW infants: relationship to severe intraventricular hemorrhage. J Perinatol. 
2008; 28:759–65. [PubMed: 18596706] 
30. Kasper DC, Mechtler TP, Bohm J, Petricevic L, Gleiss A, Spergser J, et al. In utero exposure to 
Ureaplasma spp. is associated with increased rate of bronchopulmonary dysplasia and 
intraventricular hemorrhage in preterm infants. J Perinat Med. 2011; 39:331–6. [PubMed: 
21526978] 
31. Martinez E, Figueroa R, Garry D, Visintainer P, Patel K, Verma U, et al. Elevated Amniotic Fluid 
Interleukin-6 as a Predictor of Neonatal Periventricular Leukomalacia and Intraventricular 
Hemorrhage. J Matern Fetal Investig. 1998; 8:101–7.
32. Thomas W, Speer CP. Chorioamnionitis: important risk factor or innocent bystander for neonatal 
outcome? Neonatology. 2011; 99:177–87. [PubMed: 20881433] 
33. Leviton A, Dammann O, Durum SK. The adaptive immune response in neonatal cerebral white 
matter damage. Ann Neurol. 2005; 58:821–8. [PubMed: 16250014] 
34. Verma U, Tejani N, Klein S, Reale MR, Beneck D, Figueroa R, et al. Obstetric antecedents of 
intraventricular hemorrhage and periventricular leukomalacia in the low-birth-weight neonate. Am 
J Obstet Gynecol. 1997; 176:275–81. [PubMed: 9065168] 
35. Linder N, Haskin O, Levit O, Klinger G, Prince T, Naor N, et al. Risk factors for intraventricular 
hemorrhage in very low birth weight premature infants: a retrospective case-control study. 
Pediatrics. 2003; 111:e590–5. [PubMed: 12728115] 
36. Morales WJ, Koerten J. Obstetric management and intraventricular hemorrhage in very-low-birth-
weight infants. Obstet Gynecol. 1986; 68:35–40. [PubMed: 3725257] 
37. Ferrari B, Tonni G, Luzietti R, Ciarlini G, Vadora E, Merialdi A. Neonatal complications and risk 
of intraventricular-periventricular hemorrhage. Clin Exp Obstet Gynecol. 1992; 19:253–8. 
[PubMed: 1294347] 
38. Levene MI, Fawer CL, Lamont RF. Risk factors in the development of intraventricular 
haemorrhage in the preterm neonate. Arch Dis Child. 1982; 57:410–7. [PubMed: 7092304] 
39. Heljic S, Maksic H, Buljina A. Hemorrhagic and hypoxic-ischemic brain lesions in premature 
infants on artificial ventilation. Med Arh. 2000; 54:265–7. [PubMed: 11219899] 
40. Hill A, Volpe JJ. Seizures, hypoxic-ischemic brain injury, and intraventricular hemorrhage in the 
newborn. Ann Neurol. 1981; 10:109–21. [PubMed: 7283398] 
41. Lou HC. Perinatal hypoxic-ischaemic brain damage and intraventricular haemorrhage. Baillieres 
Clin Obstet Gynaecol. 1988; 2:213–20. [PubMed: 3046802] 
42. Gomez R, Romero R, Edwin SS, David C. Pathogenesis of preterm labor and preterm premature 
rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am. 1997; 
11:135–76. [PubMed: 9067790] 
43. Romero R, Mazor M, Wu YK, Sirtori M, Oyarzun E, Mitchell MD, et al. Infection in the 
pathogenesis of preterm labor. Semin Perinatol. 1988; 12:262–79. [PubMed: 3065940] 
OH et al. Page 9
J Perinat Med. Author manuscript; available in PMC 2018 March 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
44. Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, et al. Infection and labor. V. 
Prevalence, microbiology, and clinical significance of intraamniotic infection in women with 
preterm labor and intact membranes. Am J Obstet Gynecol. 1989; 161:817–24. [PubMed: 
2675611] 
45. Romero R, Shamma F, Avila C, Jimenez C, Callahan R, Nores J, et al. Infection and labor. VI. 
Prevalence, microbiology, and clinical significance of intraamniotic infection in twin gestations 
with preterm labor. Am J Obstet Gynecol. 1990; 163:757–61. [PubMed: 2403156] 
46. Angus SR, Segel SY, Hsu CD, Locksmith GJ, Clark P, Sammel MD, et al. Amniotic fluid matrix 
metalloproteinase-8 indicates intra-amniotic infection. Am J Obstet Gynecol. 2001; 185:1232–8. 
[PubMed: 11717662] 
47. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth and 
subclinical infection. Am J Obstet Gynecol. 1992; 166:1515–28. [PubMed: 1595807] 
48. Yoon BH, Romero R, Park JS, Chang JW, Kim YA, Kim JC, et al. Microbial invasion of the 
amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, 
amniotic, and maternal compartments. Am J Obstet Gynecol. 1998; 179:1254–60. [PubMed: 
9822511] 
49. Yoon BH, Romero R, Moon JB, Shim SS, Kim M, Kim G, et al. Clinical significance of intra-
amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 
2001; 185:1130–6. [PubMed: 11717646] 
50. Yoon BH, Romero R, Kim M, Kim EC, Kim T, Park JS, et al. Clinical implications of detection of 
Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet 
Gynecol. 2000; 183:1130–7. [PubMed: 11084554] 
51. Yoon BH, Chang JW, Romero R. Isolation of Ureaplasma urealyticum from the amniotic cavity 
and adverse outcome in preterm labor. Obstet Gynecol. 1998; 92:77–82. [PubMed: 9649098] 
52. Oh KJ, Lee SE, Jung H, Kim G, Romero R, Yoon BH. Detection of ureaplasmas by the polymerase 
chain reaction in the amniotic fluid of patients with cervical insufficiency. J Perinat Med. 2010; 
38:261–8. [PubMed: 20192887] 
53. Gomez-Lopez N, Romero R, Plazyo O, Panaitescu B, Furcron AE, Miller D, et al. Intra-Amniotic 
Administration of HMGB1 Induces Spontaneous Preterm Labor and Birth. Am J Reprod Immunol. 
2016; 75:3–7. [PubMed: 26781934] 
54. Kim SM, Romero R, Lee J, Chaemsaithong P, Lee MW, Chaiyasit N, et al. About one-half of early 
spontaneous preterm deliveries can be identified by a rapid matrix metalloproteinase-8 (MMP-8) 
bedside test at the time of mid-trimester genetic amniocentesis. J Matern Fetal Neonatal Med. 
2016; 29:2414–21. [PubMed: 26643648] 
55. Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science. 2014; 
345:760–5. [PubMed: 25124429] 
56. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel LA, Nien JK. Inflammation in preterm 
and term labour and delivery. Semin Fetal Neonatal Med. 2006; 11:317–26. [PubMed: 16839830] 
57. Shim SS, Romero R, Hong JS, Park CW, Jun JK, Kim BI, et al. Clinical significance of intra-
amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet 
Gynecol. 2004; 191:1339–45. [PubMed: 15507963] 
58. Maymon E, Romero R, Chaiworapongsa T, Berman S, Conoscenti G, Gomez R, et al. Amniotic 
fluid matrix metalloproteinase-8 in preterm labor with intact membranes. Am J Obstet Gynecol. 
2001; 185:1149–55. [PubMed: 11717649] 
59. Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM. Acute chorioamnionitis 
and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol. 2015; 
213:S29–52. [PubMed: 26428501] 
60. Romero R, Mazaki-Tovi S, Vaisbuch E, Kusanovic JP, Chaiworapongsa T, Gomez R, et al. 
Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. 
J Matern Fetal Neonatal Med. 2010; 23:1344–59. [PubMed: 20504069] 
61. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, et al. The preterm parturition 
syndrome. BJOG. 2006; 113(Suppl 3):17–42.
OH et al. Page 10
J Perinat Med. Author manuscript; available in PMC 2018 March 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
62. DiGiulio DB, Romero R, Amogan HP, Kusanovic JP, Bik EM, Gotsch F, et al. Microbial 
prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and 
culture-based investigation. PLoS One. 2008; 3:e3056. [PubMed: 18725970] 
63. Yoon BH, Kim CJ, Romero R, Jun JK, Park KH, Choi ST, et al. Experimentally induced 
intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol. 
1997; 177:797–802. [PubMed: 9369822] 
64. Dean JM, Farrag D, Zahkouk SA, El Zawahry EY, Hagberg H, Kjellmer I, et al. Cerebellar white 
matter injury following systemic endotoxemia in preterm fetal sheep. Neuroscience. 2009; 
160:606–15. [PubMed: 19285118] 
65. Gavilanes AW, Strackx E, Kramer BW, Gantert M, Van den Hove D, Steinbusch H, et al. 
Chorioamnionitis induced by intraamniotic lipopolysaccharide resulted in an interval-dependent 
increase in central nervous system injury in the fetal sheep. Am J Obstet Gynecol. 2009; 
200:437e1–8. [PubMed: 19217590] 
66. Lodygensky GA, West T, Stump M, Holtzman DM, Inder TE, Neil JJ. In vivo MRI analysis of an 
inflammatory injury in the developing brain. Brain Behav Immun. 2010; 24:759–67. [PubMed: 
19945527] 
67. Wallace K, Veerisetty S, Paul I, May W, Miguel-Hidalgo JJ, Bennett W. Prenatal infection 
decreases calbindin, decreases Purkinje cell volume and density and produces long-term motor 
deficits in Sprague-Dawley rats. Dev Neurosci. 2010; 32:302–12. [PubMed: 20948182] 
68. Sarkar S, Kaplan C, Wiswell TE, Spitzer AR. Histological chorioamnionitis and the risk of early 
intraventricular hemorrhage in infants born < or =28 weeks gestation. J Perinatol. 2005; 25:749–
52. [PubMed: 16237461] 
69. Richardson BS, Wakim E, daSilva O, Walton J. Preterm histologic chorioamnionitis: impact on 
cord gas and pH values and neonatal outcome. Am J Obstet Gynecol. 2006; 195:1357–65. 
[PubMed: 16677589] 
70. Rocha G, Proenca E, Quintas C, Rodrigues T, Guimaraes H. Chorioamnionitis and brain damage in 
the preterm newborn. J Matern Fetal Neonatal Med. 2007; 20:745–9. [PubMed: 17763276] 
71. Moss TJ, Nitsos I, Kramer BW, Ikegami M, Newnham JP, Jobe AH. Intra-amniotic endotoxin 
induces lung maturation by direct effects on the developing respiratory tract in preterm sheep. Am 
J Obstet Gynecol. 2002; 187:1059–65. [PubMed: 12389005] 
72. Jobe AH, Newnham JP, Willet KE, Moss TJ, Gore Ervin M, Padbury JF, et al. Endotoxin-induced 
lung maturation in preterm lambs is not mediated by cortisol. Am J Respir Crit Care Med. 2000; 
162:1656–61. [PubMed: 11069792] 
73. Shimoya K, Taniguchi T, Matsuzaki N, Moriyama A, Murata Y, Kitajima H, et al. 
Chorioamnionitis decreased incidence of respiratory distress syndrome by elevating fetal 
interleukin-6 serum concentration. Hum Reprod. 2000; 15:2234–40. [PubMed: 11006206] 
74. Lee J, Seong HS, Kim BJ, Jun JK, Romero R, Yoon BH. Evidence to support that spontaneous 
preterm labor is adaptive in nature: neonatal RDS is more common in ‘indicated’ than in 
‘spontaneous’ preterm birth. J Perinat Med. 2009; 37:53–8. [PubMed: 19099368] 
75. Tsuda H, Takahashi Y, Iwagaki S, Kawabata I, Hayakawa H, Kotani T, et al. Intra-amniotic 
infection increases amniotic lamellar body count before 34 weeks of gestation. J Matern Fetal 
Neonatal Med. 2010; 23:1230–6. [PubMed: 20158396] 
76. Morken NH, Kallen K, Jacobsson B. Outcomes of preterm children according to type of delivery 
onset: a nationwide population-based study. Paediatr Perinat Epidemiol. 2007; 21:458–64. 
[PubMed: 17697076] 
77. Park JS, Romero R, Yoon BH, Moon JB, Oh SY, Han SY, et al. The relationship between amniotic 
fluid matrix metalloproteinase-8 and funisitis. Am J Obstet Gynecol. 2001; 185:1156–61. 
[PubMed: 11717650] 
78. Salafia CM, Minior VK, Rosenkrantz TS, Pezzullo JC, Popek EJ, Cusick W, et al. Maternal, 
placental, and neonatal associations with early germinal matrix/intraventricular hemorrhage in 
infants born before 32 weeks’ gestation. Am J Perinatol. 1995; 12:429–36. [PubMed: 8579656] 
79. Huleihel M, Golan H, Hallak M. Intrauterine infection/inflammation during pregnancy and 
offspring brain damages: possible mechanisms involved. Reprod Biol Endocrinol. 2004; 2:17. 
[PubMed: 15104793] 
OH et al. Page 11
J Perinat Med. Author manuscript; available in PMC 2018 March 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
80. Ugwumadu A. Infection and fetal neurologic injury. Curr Opin Obstet Gynecol. 2006; 18:106–11. 
[PubMed: 16601469] 
81. Perlman JM. White matter injury in the preterm infant: an important determination of abnormal 
neurodevelopment outcome. Early Hum Dev. 1998; 53:99–120. [PubMed: 10195704] 
82. Andrews T, Zhang P, Bhat NR. TNFalpha potentiates IFNgamma-induced cell death in 
oligodendrocyte progenitors. J Neurosci Res. 1998; 54:574–83. [PubMed: 9843148] 
83. Kahn MA, De Vellis J. Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 
family of cytokines. Glia. 1994; 12:87–98. [PubMed: 7532622] 
84. Hurwitz AA, Lyman WD, Guida MP, Calderon TM, Berman JW. Tumor necrosis factor alpha 
induces adhesion molecule expression on human fetal astrocytes. J Exp Med. 1992; 176:1631–6. 
[PubMed: 1281214] 
85. Cobo T, Palacio M, Martinez-Terron M, Navarro-Sastre A, Bosch J, Filella X, et al. Clinical and 
inflammatory markers in amniotic fluid as predictors of adverse outcomes in preterm premature 
rupture of membranes. Am J Obstet Gynecol. 2011; 205:126e1–8. [PubMed: 21621184] 
86. Kim KW, Romero R, Park HS, Park CW, Shim SS, Jun JK, et al. A rapid matrix 
metalloproteinase-8 bedside test for the detection of intraamniotic inflammation in women with 
preterm premature rupture of membranes. Am J Obstet Gynecol. 2007; 197:292e1–5. [PubMed: 
17826425] 
87. Jacobsson B, Mattsby-Baltzer I, Andersch B, Bokstrom H, Holst RM, Nikolaitchouk N, et al. 
Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women 
with preterm prelabor rupture of membranes. Acta Obstet Gynecol Scand. 2003; 82:423–31. 
[PubMed: 12752072] 
88. Jacobsson B, Mattsby-Baltzer I, Andersch B, Bokstrom H, Holst RM, Wennerholm UB, et al. 
Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women in 
preterm labor. Acta Obstet Gynecol Scand. 2003; 82:120–8. [PubMed: 12648172] 
89. Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi J-H, et al. Amniotic fluid inflammatory 
cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter 
lesions, and cerebral palsy. Am J Obstet Gynecol. 1997; 177:19–26. [PubMed: 9240577] 
90. Oh KJ, Park KH, Kim SN, Jeong EH, Lee SY, Yoon HY. Predictive value of intra-amniotic and 
serum markers for inflammatory lesions of preterm placenta. Placenta. 2011; 32:732–6. [PubMed: 
21839511] 
91. Lee SE, Romero R, Jung H, Park CW, Park JS, Yoon BH. The intensity of the fetal inflammatory 
response in intraamniotic inflammation with and without microbial invasion of the amniotic cavity. 
Am J Obstet Gynecol. 2007; 197:294e1–6. [PubMed: 17826426] 
92. Lee SE, Romero R, Park CW, Jun JK, Yoon BH. The frequency and significance of intraamniotic 
inflammation in patients with cervical insufficiency. Am J Obstet Gynecol. 2008; 198:633e1–8. 
[PubMed: 18342290] 
93. Nien JK, Yoon BH, Espinoza J, Kusanovic JP, Erez O, Soto E, et al. A rapid MMP-8 bedside test 
for the detection of intra-amniotic inflammation identifies patients at risk for imminent preterm 
delivery. Am J Obstet Gynecol. 2006; 195:1025–30. [PubMed: 17000236] 
94. Gotsch F, Romero R, Chaiworapongsa T, Erez O, Vaisbuch E, Espinoza J, et al. Evidence of the 
involvement of caspase-1 under physiologic and pathologic cellular stress during human 
pregnancy: a link between the inflammasome and parturition. J Matern Fetal Neonatal Med. 2008; 
21:605–16. [PubMed: 18828051] 
95. Holst RM, Laurini R, Jacobsson B, Samuelsson E, Savman K, Doverhag C, et al. Expression of 
cytokines and chemokines in cervical and amniotic fluid: relationship to histological 
chorioamnionitis. J Matern Fetal Neonatal Med. 2007; 20:885–93. [PubMed: 18050018] 
96. Mazaki-Tovi S, Romero R, Kusanovic JP, Erez O, Gotsch F, Mittal P, et al. Visfatin/Pre-B cell 
colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm 
labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in 
preterm parturition. J Perinat Med. 2008; 36:485–96. [PubMed: 18598235] 
97. Bashiri A, Horowitz S, Huleihel M, Hackmon R, Dukler D, Mazor M. Elevated concentrations of 
interleukin-6 in intra-amniotic infection with Ureaplasma urealyticum in asymptomatic women 
during genetic amniocentesis. Acta Obstet Gynecol Scand. 1999; 78:379–82. [PubMed: 10326880] 
OH et al. Page 12
J Perinat Med. Author manuscript; available in PMC 2018 March 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
98. Biggio JR Jr, Ramsey PS, Cliver SP, Lyon MD, Goldenberg RL, Wenstrom KD. Midtrimester 
amniotic fluid matrix metalloproteinase-8 (MMP-8) levels above the 90th percentile are a marker 
for subsequent preterm premature rupture of membranes. Am J Obstet Gynecol. 2005; 192:109–
13. [PubMed: 15672011] 
99. Fortunato SJ, Menon R. Screening of novel matrix metalloproteinases (MMPs) in human fetal 
membranes. J Assist Reprod Genet. 2002; 19:483–6. [PubMed: 12416653] 
100. Maymon E, Romero R, Pacora P, Gomez R, Athayde N, Edwin S, et al. Human neutrophil 
collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and 
intrauterine infection. Am J Obstet Gynecol. 2000; 183:94–9. [PubMed: 10920315] 
101. Andrews WW, Hauth JC, Goldenberg RL, Gomez R, Romero R, Cassell GH. Amniotic fluid 
interleukin-6: correlation with upper genital tract microbial colonization and gestational age in 
women delivered after spontaneous labor versus indicated delivery. Am J Obstet Gynecol. 1995; 
173:606–12. [PubMed: 7645642] 
102. Coultrip LL, Lien JM, Gomez R, Kapernick P, Khoury A, Grossman JH. The value of amniotic 
fluid interleukin-6 determination in patients with preterm labor and intact membranes in the 
detection of microbial invasion of the amniotic cavity. Am J Obstet Gynecol. 1994; 171:901–11. 
[PubMed: 7943100] 
103. Romero R, Yoon BH, Kenney JS, Gomez R, Allison AC, Sehgal PB. Amniotic fluid interleukin-6 
determinations are of diagnostic and prognostic value in preterm labor. Am J Reprod Immunol. 
1993; 30:167–83. [PubMed: 8311926] 
104. Park CW, Lee SM, Park JS, Jun JK, Romero R, Yoon BH. The antenatal identification of funisitis 
with a rapid MMP-8 bedside test. J Perinat Med. 2008; 36:497–502. [PubMed: 19127606] 
105. Romero R, Quintero R, Nores J, Avila C, Mazor M, Hanaoka S, et al. Amniotic fluid white blood 
cell count: a rapid and simple test to diagnose microbial invasion of the amniotic cavity and 
predict preterm delivery. Am J Obstet Gynecol. 1991; 165:821–30. [PubMed: 1951538] 
106. Yoon BH, Jun JK, Park KH, Syn HC, Gomez R, Romero R. Serum C-reactive protein, white 
blood cell count, and amniotic fluid white blood cell count in women with preterm premature 
rupture of membranes. Obstet Gynecol. 1996; 88:1034–40. [PubMed: 8942849] 
107. Yoon BH, Yang SH, Jun JK, Park KH, Kim CJ, Romero R. Maternal blood C-reactive protein, 
white blood cell count, and temperature in preterm labor: a comparison with amniotic fluid white 
blood cell count. Obstet Gynecol. 1996; 87:231–7. [PubMed: 8559530] 
108. Pacora P, Chaiworapongsa T, Maymon E, Kim YM, Gomez R, Yoon BH, et al. Funisitis and 
chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J 
Matern Fetal Neonatal Med. 2002; 11:18–25. [PubMed: 12380603] 
109. Kim CJ, Yoon BH, Park SS, Kim MH, Chi JG. Acute funisitis of preterm but not term placentas is 
associated with severe fetal inflammatory response. Hum Pathol. 2001; 32:623–9. [PubMed: 
11431717] 
110. Park CW, Moon KC, Park JS, Jun JK, Romero R, Yoon BH. The involvement of human amnion in 
histologic chorioamnionitis is an indicator that a fetal and an intra-amniotic inflammatory 
response is more likely and severe: clinical implications. Placenta. 2009; 30:56–61. [PubMed: 
19046766] 
111. Romero R, Salafia CM, Athanassiadis AP, Hanaoka S, Mazor M, Sepulveda W, et al. The 
relationship between acute inflammatory lesions of the preterm placenta and amniotic fluid 
microbiology. Am J Obstet Gynecol. 1992; 166:1382–8. [PubMed: 1595794] 
112. Smulian JC, Vintzileos AM, Lai YL, Santiago J, Shen-Schwarz S, Campbell WA. Maternal 
chorioamnionitis and umbilical vein interleukin-6 levels for identifying early neonatal sepsis. J 
Matern Fetal Med. 1999; 8:88–94. [PubMed: 10338061] 
113. Yoon BH, Romero R, Shim JY, Shim SS, Kim CJ, Jun JK. C-reactive protein in umbilical cord 
blood: a simple and widely available clinical method to assess the risk of amniotic fluid infection 
and funisitis. J Matern Fetal Neonatal Med. 2003; 14:85–90. [PubMed: 14629087] 
114. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, et al. The relationship among 
inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 
concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol. 2000; 
183:1124–9. [PubMed: 11084553] 
OH et al. Page 13
J Perinat Med. Author manuscript; available in PMC 2018 March 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
115. Chaiworapongsa T, Romero R, Kim JC, Kim YM, Blackwell SC, Yoon BH, et al. Evidence for 
fetal involvement in the pathologic process of clinical chorioamnionitis. Am J Obstet Gynecol. 
2002; 186:1178–82. [PubMed: 12066094] 
116. Romero R, Chaemsaithong P, Docheva N, Korzeniewski SJ, Tarca AL, Bhatti G, et al. Clinical 
chorioamnionitis at term V: umbilical cord plasma cytokine profile in the context of a systemic 
maternal inflammatory response. J Perinat Med. 2016; 44:53–76. [PubMed: 26360486] 
117. Moon JB, Kim JC, Yoon BH, Romero R, Kim G, Oh SY, et al. Amniotic fluid matrix 
metalloproteinase-8 and the development of cerebral palsy. J Perinat Med. 2002; 30:301–6. 
[PubMed: 12235718] 
118. Seong HS, Lee SE, Kang JH, Romero R, Yoon BH. The frequency of microbial invasion of the 
amniotic cavity and histologic chorioamnionitis in women at term with intact membranes in the 
presence or absence of labor. Am J Obstet Gynecol. 2008; 199:375e1–5. [PubMed: 18928978] 
119. Sampson JE, Theve RP, Blatman RN, Shipp TD, Bianchi DW, Ward BE, et al. Fetal origin of 
amniotic fluid polymorphonuclear leukocytes. Am J Obstet Gynecol. 1997; 176:77–81. 
[PubMed: 9024093] 
120. Sun H, Zhou Y, Xiong H, Kang W, Xu B, Liu D, et al. Prognosis of very preterm infants with 
severe respiratory distress syndrome receiving mechanical ventilation. Lung. 2015; 193:249–54. 
[PubMed: 25583617] 
121. Vergani P, Patane L, Doria P, Borroni C, Cappellini A, Pezzullo JC, et al. Risk factors for neonatal 
intraventricular haemorrhage in spontaneous prematurity at 32 weeks gestation or less. Placenta. 
2000; 21:402–7. [PubMed: 10833376] 
122. Mullaart RA, Hopman JC, Rotteveel JJ, Daniels O, Stoelinga GB, De Haan AF. Cerebral blood 
flow fluctuation in neonatal respiratory distress and periventricular haemorrhage. Early Hum 
Dev. 1994; 37:179–85. [PubMed: 7925076] 
123. Kusuda S, Ito Y, Kim TJ, Miyagi N, Shishida N, Tanaka Y. Cerebral hemodynamics after 
exogenous surfactant administration for respiratory distress syndrome in piglet model. J Perinat 
Med. 2000; 28:363–71. [PubMed: 11125926] 
124. Perlman JM, Goodman S, Kreusser KL, Volpe JJ. Reduction in intraventricular hemorrhage by 
elimination of fluctuating cerebral blood-flow velocity in preterm infants with respiratory distress 
syndrome. N Engl J Med. 1985; 312:1353–7. [PubMed: 3887165] 
125. Lemmers PM, Toet M, van Schelven LJ, van Bel F. Cerebral oxygenation and cerebral oxygen 
extraction in the preterm infant: the impact of respiratory distress syndrome. Exp Brain Res. 
2006; 173:458–67. [PubMed: 16506004] 
126. Lauterbach MD, Raz S, Sander CJ. Neonatal hypoxic risk in preterm birth infants: the influence 
of sex and severity of respiratory distress on cognitive recovery. Neuropsychology. 2001; 15:411–
20. [PubMed: 11499996] 
127. Nelson KB, Grether JK. Potentially asphyxiating conditions and spastic cerebral palsy in infants 
of normal birth weight. Am J Obstet Gynecol. 1998; 179:507–13. [PubMed: 9731861] 
128. Girard S, Kadhim H, Beaudet N, Sarret P, Sebire G. Developmental motor deficits induced by 
combined fetal exposure to lipopolysaccharide and early neonatal hypoxia/ischemia: a novel 
animal model for cerebral palsy in very premature infants. Neuroscience. 2009; 158:673–82. 
[PubMed: 19010395] 
129. Larouche A, Roy M, Kadhim H, Tsanaclis AM, Fortin D, Sebire G. Neuronal injuries induced by 
perinatal hypoxic-ischemic insults are potentiated by prenatal exposure to lipopolysaccharide: 
animal model for perinatally acquired encephalopathy. Dev Neurosci. 2005; 27:134–42. 
[PubMed: 16046847] 
130. Eklind S, Mallard C, Leverin AL, Gilland E, Blomgren K, Mattsby-Baltzer I, et al. Bacterial 
endotoxin sensitizes the immature brain to hypoxic--ischaemic injury. Eur J Neurosci. 2001; 
13:1101–6. [PubMed: 11285007] 
131. Hagberg H, Peebles D, Mallard C. Models of white matter injury: comparison of infectious, 
hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev. 2002; 8:30–8. 
[PubMed: 11921384] 
132. Choi EK, Park D, Kim TK, Lee SH, Bae DK, Yang G, et al. Animal models of periventricular 
leukomalacia. Lab Anim Res. 2011; 27:77–84. [PubMed: 21826166] 
OH et al. Page 14
J Perinat Med. Author manuscript; available in PMC 2018 March 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
133. Brochu ME, Girard S, Lavoie K, Sebire G. Developmental regulation of the neuroinflammatory 
responses to LPS and/or hypoxia-ischemia between preterm and term neonates: An experimental 
study. J Neuroinflammation. 2011; 8:55. [PubMed: 21599903] 
134. Maxwell JR, Denson JL, Joste NE, Robinson S, Jantzie LL. Combined in utero hypoxia-ischemia 
and lipopolysaccharide administration in rats induces chorioamnionitis and a fetal inflammatory 
response syndrome. Placenta. 2015; 36:1378–84. [PubMed: 26601766] 
135. Jantzie LL, Corbett CJ, Berglass J, Firl DJ, Flores J, Mannix R, et al. Complex pattern of 
interaction between in utero hypoxia-ischemia and intra-amniotic inflammation disrupts brain 
development and motor function. J Neuroinflammation. 2014; 11:131. [PubMed: 25082427] 
136. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women 
at risk of preterm birth. Cochrane Database Syst Rev. 2006:CD004454. [PubMed: 16856047] 
137. Deulofeut R, Sola A, Lee B, Buchter S, Rahman M, Rogido M. The impact of vaginal delivery in 
premature infants weighing less than 1,251 grams. Obstet Gynecol. 2005; 105:525–31. [PubMed: 
15738019] 
138. Ment LR, Oh W, Ehrenkranz RA, Philip AG, Duncan CC, Makuch RW. Antenatal steroids, 
delivery mode, and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol. 1995; 
172:795–800. [PubMed: 7892866] 
139. Dani C, Poggi C, Bertini G, Pratesi S, Di Tommaso M, Scarselli G, et al. Method of delivery and 
intraventricular haemorrhage in extremely preterm infants. J Matern Fetal Neonatal Med. 2010; 
23:1419–23. [PubMed: 20236026] 
140. Minguez-Milio JA, Alcazar JL, Auba M, Ruiz-Zambrana A, Minguez J. Perinatal outcome and 
long-term follow-up of extremely low birth weight infants depending on the mode of delivery. J 
Matern Fetal Neonatal Med. 2011; 24:1235–8. [PubMed: 21381880] 
141. Malloy MH, Onstad L, Wright E. The effect of cesarean delivery on birth outcome in very low 
birth weight infants. National Institute of Child Health and Human Development Neonatal 
Research Network. Obstet Gynecol. 1991; 77:498–503. [PubMed: 2002969] 
OH et al. Page 15
J Perinat Med. Author manuscript; available in PMC 2018 March 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. The rate of the development of intraventricular hemorrhage (IVH) according to the 
presence or absence of intra-amniotic inflammation and the occurrence of neonatal respiratory 
distress syndrome (RDS)
Intra-amniotic inflammation was defined as an elevated amniotic fluid MMP-8 concentration 
(>23 ng/mL). *Each P-value was adjusted for gestational age at birth. †P-value could not be 
adjusted for gestational age at birth because no patient without intra-amniotic inflammation 
and RDS had an IVH. Patients with intra-amniotic inflammation and neonatal RDS had a 
higher risk of the development of IVH than those with neonatal RDS alone [odds ratio (OR), 
5.63; 95% CI, 1.03–30.9; P<0.05] and those with intra-amniotic inflammation alone [OR, 
4.56; 95% CI, 1.08–19.3; P<0.05) after adjusting for gestational age at birth.
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Table 1
Characteristics of neurosonographic examinations performed in the study population
Characteristics Number of neonates (n=207)
No. of neurosonographic examinations
 1 79.2% (164)
 2 17.9% (37)
 3 1.9% (4)
 4 1.0% (2)
Postnatal day at neurosonographic examination
 ≤ 3days 63.8% (132)
 4–7days 21.3% (44)
 Both (≤ 3days and 4–7days) 15.0% (31)
Grade of PV-IVH by neurosonographic examination*
 0 67.6% (140)
 I 25.6% (53)
 II 4.8% (10)
 III 1.9% (4)
IVH†
 Yes 6.8% (14)
 No 93.2% (193)
Values are given as % (n).
*Sonographic finding of PV-IVH was graded by McMenamin’s classification.
†
IVH was defined as PV-IVH of grade II or higher by McMenamin’s classification.
IVH: intraventricular hemorrhage; PV-IVH: periventricular-intraventricular hemorrhage.
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Table 2
Clinical characteristics of the study population according to the development of intraventricular hemorrhage
Characteristics IVH (−) (n=193) IVH (+) (n=14) P-value
Maternal age (years) 31.4 ± 4.4 31.6 ± 4.3 NS
Nulliparity 48.2% (93/193) 35.7% (5/14) NS
Gestational age at birth (weeks) 29.8 ± 2.2 27.8 ± 2.3 0.003
Antenatal corticosteroid use 74.1% (143/193) 92.9% (13/14) NS
Cesarean delivery 69.4% (134/193) 64.3% (9/14) NS
Spontaneous preterm birth 55.4% (107/193) 78.6% (11/14) NS
Male 46.1% (89/193) 71.4% (10/14) 0.095
Birthweight, grams 1282 ± 427 1086 ± 456 0.095
Fetal growth restriction 26.9% (52/193) 21.4% (3/14) NS
Apgar score <4 at 1min 27.5% (53/193) 42.9% (6/14) NS
Apgar score <7 at 5min 44.6% (86/193) 64.3% (9/14) NS
Umbilical arterial pH <7.15* 10.2% (18/176) 15.4% (2/13) NS
Respiratory distress syndrome (RDS) 32.6% (63/193) 64.3% (9/14) 0.022
AF MMP-8 concentration (ng/mL)† 6.0 (0.3–6386.3) 358.0 (0.3–4202.7) 0.011
 AF MMP-8 >23 ng/mL† 39.9% (73/183) 78.6% (11/14) 0.009
Acute histologic chorioamnionitis‡ 41.4% (72/174) 75.0% (9/12) 0.033
Acute funisitis§ 20.5% (36/176) 41.7% (5/12) NS
Values are given as mean ± standard deviation or median (range) or % (n/N).
*
Eighteen patients whose umbilical arterial pH was not measured were excluded from the analysis.
†
MMP-8 concentration was not measured in 10 patients because of the lack of remaining AF.
‡
Twenty-one patients were excluded because their placental histologic examinations were not performed.
§Nineteen patients were excluded because the presence or absence of funisitis was not determined.
AF: amniotic fluid; IVH: intraventricular hemorrhage; MMP-8: matrix metalloproteinase-8; NS, not significant.
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